참고문헌
- 全國韓醫科大學 肝系內科學敎授. 肝系內科學. 서울, 東洋學硏究院出版部, pp 323-330, 1984
- 김병철, 김진원, 정병주, 우성호, 심효주, 나유진, 김용호, 서호석, 이원희. 복수 동반 간병변 환자의 平胃散 合 胃苓湯加味方 투여 호전 1례. 대한한방내과학회지 27(4):962-968, 2006
- Brewster, S.F., Simons, J.W. Gene therapy in urological oncology: principles, strategies and potential. Eur. Urol. 25(3):177-182, 1994 https://doi.org/10.1159/000475279
- Taplin, M.E., Bubley, G.J., Shuster, T.D., Frantz, M.E., Spooner, A.E., Ogata, G.K., Keer, H.N, Balk, S.P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332(21):1393-1398, 1995 https://doi.org/10.1056/NEJM199505253322101
- Gittes, R.F. Carcinoma of the prostate. N. Engl. J. Med. 324(4):236-245, 1991 https://doi.org/10.1056/NEJM199101243240406
- Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H., Hittmair, A. Androgen receptor status of lymph node metastases from prostate cancer. Prostate 28(2):129-135, 1996 https://doi.org/10.1002/(SICI)1097-0045(199602)28:2<129::AID-PROS9>3.0.CO;2-B
- Jenster, G. The role of the androgen receptor in the development and progression of prostate cancer. Semin. Oncol. 26(4):407-421, 1999
- Edwards, J., Krishna, N.S., Grigor, K.M., Bartlett, J.M. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br. J. Cancer. 89(3):552-556, 2003 https://doi.org/10.1038/sj.bjc.6601127
- Balk, S.P. Androgen receptor as a target in androgen-independent prostate cancer. Urology 60(3-1):132-138, 138-139, 2002 https://doi.org/10.1016/S0090-4295(02)01593-5
- Chen, C.D., Welsbie, D.S., Tran, C., Baek, S.H., Chen, R., Vessella, R., Rosenfeld, M.G., Sawyers, C. L. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10(1):33-39, 2004 https://doi.org/10.1038/nm972
- Santos, A.F., Huang, H., Tindall, D.J. The androgen receptor: a potential target for therapy of prostate cancer. Steroids 69(2):79-85, 2004 https://doi.org/10.1016/j.steroids.2003.10.005
- Taplin, M.E., Balk, S.P. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J. Cell. Biochem. 91(3):483-490, 2004 https://doi.org/10.1002/jcb.10653
- Oh, W.K., Kantoff, P.W., Weinberg, V., Jones, G., Rini, B.I., Derynck, M.K., Bok, R., Smith, M.R., Bubley, G.J., Rosen, R.T., DiPaola, R.S., Small, E.J. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Clin. Oncol. 22(18):3705-3712, 2004 https://doi.org/10.1200/JCO.2004.10.195
- Walsh, P.C. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J. Urol. 173(6):1966-1967, 2005
- Pfeifer, B.L., Pirani, J.F., Hamann, S.R., Klippel, K.F. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int. 85(4):481-485, 2000 https://doi.org/10.1046/j.1464-410x.2000.00476.x
- Small, E.J., Frohlich, M.W., Bok, R., Shinohara, K., Grossfeld, G., Rozenblat, Z., Kelly, W.K., Corry, M., Reese, D.M. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J. Clin. Oncol. 18(21):3595-3603, 2000 https://doi.org/10.1200/JCO.2000.18.21.3595
- Kwon, K.B., Kim, E.K., Shin, B.C., Seo, E.A., Park, J.W., Kim, J.S., Park, B.H., Ryu, D.G. Induction of apoptosis by takrisodokyeum through generation of hydrogen peroxide and activation of caspase-3 in HL-60 cells. Life Sci. 73(15):1895-1906, 2003 https://doi.org/10.1016/S0024-3205(03)00559-9
- Yang, K.H. Study on Effect of Takrisodokyeum Extract on Antitumoral Activity and Immune Response. The Korean Journal of Oriental Medical Prescription 5: 147-168, 1997
- Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65(1-2):55-63, 1983 https://doi.org/10.1016/0022-1759(83)90303-4
- Ikezoe, T., Chen, S.S., Yang, Y., Heber, D., Taguchi, H., Koeffler, H.P. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Int. J. Oncol. 23(5):1461-1470, 2003
- Nicholson, D.W., Thornberry, N.A. Caspases: killer proteases. Trends Biochem. Sci. 22(8):299-306, 1997
- Kwon, K.B., Park, B.H., Ryu, D.G. Chemotherapy through mitochondrial apoptosis using nutritional supplements and herbs: a brief overview. J. Bioenerg. Biomembr. 39(1):31-34, 2007 https://doi.org/10.1007/s10863-006-9056-8
- Fisher, D.E. Pathways of apoptosis and the modulation of cell death in cancer. Hematol. Oncol. Clin. North Am. 15(5):931-956, 2001 https://doi.org/10.1016/S0889-8588(05)70258-6
- Kanduc, D., Mittelman, A., Serpico, R., Sinigaglia, E.; Sinha, A.A., Natale, C., Santacroce, R., Di Corcia, M.G., Lucchese, A., Dini, L., Pani, P., Santacroce, S., Simone, S., Bucci, R., Farber, E. Cell death: apoptosis versus necrosis (review). Int. J. Oncol. 21(1):165-170, 2002
- Pang, S., Dannull, J., Kaboo, R., Xie, Y., Tso, C.L., Michel, K., deKernion, J.B., Belldegrun, A.S. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res. 57(3):495-499, 1997
- Mikolajczyk, S.D., Marker, K.M., Millar, L.S., Kumar, A., Saedi, M.S., Payne, J.K., Evans, C.L., Gasior, C.L., Linton, H.J., Carpenter, P., Rittenhouse, H.G. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Cancer Res. 61(18):6958-6963, 2001
- Yang, Y., Chisholm, G.D., Habib, F.K. The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate. Prostate 21(3):201-208, 1992 https://doi.org/10.1002/pros.2990210304
- Wang, L.G., Liu, X.M., Kreis, W., Budman, D.R. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binditorconsensus in the prom L.r of the PSA gene in LNCaP cells. Cancer Res. 57(4):714-719, 1997
- Nakamura, K., Yasunaga, Y., Segawa, T., Ko, D., Moul, J.W., Srivastava, S., Rhim, J.S. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int. J. Oncol. 21(4):825-830, 2002
- Ren, F., Zhang, S., Mitchell, S.H., Butler, R., Young, C.Y. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene, 19(15):1924-1932, 2000 https://doi.org/10.1038/sj.onc.1203511
- Xing, N., Chen, Y., Mitchell, S., Young, C.Y. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 22(3):409-414, 2001 https://doi.org/10.1093/carcin/22.3.409
- Huang, W., Shostak, Y., Tarr, P., Sawyers, C., Carey, M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274(36):25756-25768, 1999 https://doi.org/10.1074/jbc.274.36.25756
- Hsieh, T.C., Xiong, W., Traganos, F., Darzynkiewicz, Z., Wu, J.M. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol. Anticancer Res. 22(4):2051-2060, 2002
- Hsieh, T.C., Lu, X., Guo, J., Xiong, W., Kunicki, J., Darzynkiewicz, Z., Wu, J.M. Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies. Int. J. Oncol. 20(4):681-689, 2002